Catalyst Wire Dossier Catalyst Wire Dossier

Beclometasone/Formoterol

beclometasone/formoterol · Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Beclometasone/Formoterol, covering 2017-03-29 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma [Phase 3]

See pricing